Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2/3
×
INDUSTRY
×
Erlotinib Hydrochloride
×
Clear all
Filters
3
NCT03653546
2025-09-10
BM
Alpha Biopharma (Jiangsu) Co., Ltd.
Phase 2/3
Completed
492 enrolled
NCT01383148
2017-01-05
TIME
Transgene
Phase 2/3
Terminated
222 enrolled